Capital Research Global Investors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,096
Closed -$627K 431
2020
Q4
$627K Buy
15,096
+2,311
+18% +$96.3K ﹤0.01% 397
2020
Q3
$542K Buy
12,785
+987
+8% +$42.6K ﹤0.01% 397
2020
Q2
$506K Buy
11,798
+3,449
+41% +$136K ﹤0.01% 396
2020
Q1
$273K Buy
8,349
+2,666
+47% +$99.1K ﹤0.01% 386
2019
Q4
$209K Buy
5,683
+1,281
+29% +$45.4K ﹤0.01% 399
2019
Q3
$148K Buy
4,402
+4,247
+2,740% +$150K ﹤0.01% 407
2019
Q2
$6K Buy
155
+148
+2,114% +$5.86K ﹤0.01% 397
2019
Q1
$0 Hold
7
﹤0.01% 415
2018
Q4
$0 Hold
7
﹤0.01% 423
2018
Q3
$0 Hold
7
﹤0.01% 448
2018
Q2
$0 Hold
7
﹤0.01% 443
2018
Q1
$0 Hold
7
﹤0.01% 443
2017
Q4
$0 Hold
7
﹤0.01% 434
2017
Q3
$0 Buy
+7
New +$333 ﹤0.01% 435

Other funds holding FMS

Capital Research Global Investors's FMS Position: Q1 2021 in Review

Capital Research Global Investors sold out of Fresenius Medical Care (FMS) in Q1 2021, closing a stake of 15,096 shares — an estimated $627K sold.

Capital Research Global Investors first reported a position in FMS in Q3 2017 and held it in 14 quarters. The position peaked at $627K in Q4 2020. 167 funds tracked by Wall St. Rank hold FMS as of Q1 2021.

  • Capital Research Global Investors reported no remaining Fresenius Medical Care position as of Q1 2021 after selling out during the quarter.
  • Capital Research Global Investors sold 15,096 Fresenius Medical Care shares in Q1 2021, an estimated $627K.
  • Capital Research Global Investors first reported a position in Fresenius Medical Care in Q3 2017 and held it in 14 quarters.
  • Capital Research Global Investors's Fresenius Medical Care position peaked at $627K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2021.

Based on Capital Research Global Investors's 13F filing for Q1 2021, filed 14 May 2021.